Model
Edge
Alnylam Pharmaceuticals, Inc.
0001849458
Filing Type
144
Filing Date
8/28/2025
Updated
8/29/25, 2:05 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities